Double lumen port access in patients receiving allogeneic blood stem cell transplantation

Bone Marrow Transplantation

Volumn 28, Issue 11, 2001, Pages 1067-1072

  Platzbecker, U ^a,b   Illmer, T ^a   Schaich, M ^a   Freiberg Richter, J ^a   Helwig, A ^a   Plettig, R ^a   Jenke, A ^a   Ehninger, G ^a   Bornhauser M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Allogeneic; Dose reduced conditioning; Double lumen port

Indexed keywords

MYELOABLATIVE AGENT;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE LUMEN TUBE; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; INFECTION; MALE; OUTPATIENT CARE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; VEIN PUNCTURE;

ADULT; AGED; CATHETERS, INDWELLING; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035666128     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703285     Document Type: Article

References (32)

1. Dose-reduced conditioning for allogeneic blood stem cell transplantation: Durable engraftment without antithymocyte globulin
2. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports
3. Percutaneous insertion of subclavian Hickman catheters
4. Utility and safety of Hickman catheters for venous access after bone marrow transplantation
5. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation
6. Hickman catheter clots: A common occurrence despite daily heparin flushing
7. Intracardiac infections due to coagulase-negative Staphylococcus associated with Hickman catheters
8. Complications of Hickman-Broviae catheters
9. Hickman catheter infections in patients with malignancies
10. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: Analysis of overall and septic complications in 68 cases using a single type of device
11. Use of the Hickman-Crawford critical care catheter in marrow transplant recipients: A pulmonary artery catheter-adaptable central venous access
12. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems
13. Subcutaneously implanted central venous access devices in cancer patients: A prospective analysis
14. Evaluation of an implantable venous access system in a general oncology population
15. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer
16. Experience with subcutaneous infusion ports in three hundred patients
17. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients
18. Infectious morbidity associated with long-term use of venous access devices in patients with cancer
19. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac)
20. Implanted right atrial catheters for continuous infusion of solutions into dogs
21. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection
22. The fate of 100 prolonged venous access devices
23. Groshong versus Hickman catheters
24. Reliability of implantable central venous access devices in patients with cancer
25. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients
26. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients
27. Mode of chemotherapy does not affect complications with an implantable venous access device
28. Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation
29. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy
30. Complications of allogeneic bone marrow transplantation
31. Humoral coagulation and early complications after allogeneic bone marrow transplantation
32. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life